This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Although no one officially puts out a sales profession-specific hiring forecast for the upcoming year, we can aggregate Manpower, Glassdoor, Monster, and the Bureau of Labor & Statistics (BLS) projections to gain enough clarity to make a 2021 Sales Hiring Forecast. . 2021 Sales Hiring Forecast. 2021 Hiring Trends.
In this article, we give you the strategies you need to be using to grow your sales in 2021 and beyond. Study Your Competition That is Crushing It. Whether you are the leader in your industry, or just getting started, there is a lot that can be learned by studying your competition. Medical device sales teams were no exception.
We’re pleased to showcase some institutions that excel in a competitive global environment, supporting their Highly Cited Researchers in a way that encourages collaboration, facilitates career growth and accelerates highly innovative research. The National University of Singapore (NUS) is home to 32 Highly Cited Researchers in 2021.
But increased competition is on the horizon. Competition starts to heat up. In a case filed in California in 2021, Molina Healthcare claimed Jazz Pharmaceuticals engaged in a “comprehensive anticompetitive scheme to suppress generic competition for Xyrem,” abused the REMS program, and “engaged in sham patent litigation.”.
It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The first in class launches barely have time to establish before they face competition, and then the competition keeps on coming.
Have you found that your 2021 strategies for engaging with your customers aren’t working as expected? In 2020 most pharmaceutical companies had to shift strategies to reach their customers via multi-channel, digital platforms, with hope that by 2021, everything would be back to normal. But the reality is, 2021 is far from that.
Oh no, 2021 has started and our plan is already outdated! In 2020 most pharmaceutical companies continued their strategic planning as if by 2021 everything would be back to normal. But the reality is, 2021 is far from that. Leaving the competition in their wake. Need help getting a new plan in place for 2021?
As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks. Context: In August 2021, Merck & Co.
digital health sector plummeted to $15 billion from more than $29 billion in 2021, according to Rock Health. billion in 2021. Trial access equity and inclusivity are important considerations for sponsors given the results of a 2021 analysis of U.S. Venture capital and other startup investment in the U.S. digital health at $17.7
Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. Likewise, as of January 2021 hospitals must share prices online and provide plain-language descriptions of available services. That means providing more patient-friendly terminology is more than just a compliance checkbox.
percent in 2021 as employees and their families resumed care after avoiding it due to the pandemic, according to HR consultancy Mercer’s 2021 National Survey of Employer-Sponsored Health Plans report, released in December. Employee contributions for premiums increased slightly to $3,331 in 2021, up from $3,269 in 2020.
Data from the Kaiser Family Foundation (KFF) shows that between 2011 and 2021, the average premiums for family coverage rose from $15,073 to $22,221—an increase of 47.4%. Increased provider consolidation has decreased individual market competition, in which lower prices, improved productivity, and innovation can occur. As the U.S.
However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. 2021 Sales Hiring in Review. At the end of 2021, there were 4.3M
Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. For less wealthy nations, competition isn’t even a possibility. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. costs about $700.
As the pandemic persisted throughout 2021, organizations worldwide had to adapt and innovate. Sustainability continues to gain more traction : the speed at which companies integrate sustainability into their business model is crucial to create a competitive advantage over its competition.
In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. Those health insurers, in turn, use the discounts to offer more competitive premiums in a bid to attract enrollees. Pharma companies have very little control over patients’ prices for their Rxs.
The 2021 NextGen Pharma Content , taking place on March 23-24 , will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a positive emotional connection with your brand. REGISTER TODAY!
In this episode, I’m allowing you to listen to the October 2021 monthly call I recorded for my Medical Sales Academy members. I’ve never done this before, and probably won’t again, but it’s important that you up your game if you want to stay competitive in a much-changed market.
The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database. AbbVie reported a 22.7%
John Young, Pfizer’s Group President and Chief Business Officer kicked off the event with a fireside chat on the value of competitive collaboration in driving innovation and creating a roadmap to delivering important medicines to patients who need them.
Rykindo ® was approved for marketing in China in 2021 for the treatment of schizophrenia. So, Rykindo ® will have to contend with the competition of other antipsychotic LAIs as treatments for psychosis disorders. Promising schizophrenia drug faces tough competition.
AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars. The graph below shows AbbVie’s and Amgen’s pricing for Humira and Enbrel from 2003 to 2021. The last of these patents is set to expire in 2037. of the company’s Humira worldwide net revenue over that period.
As a medical sales professional looking ahead to 2021, now more than ever it is imperative to evaluate your strategy for the new year. Here are 21 tips to grow your medical sales business in 2021: 21 – Understand Pain Points. What their pain points may have been at the beginning of 2020 are most certainly going to be different in 2021.
Reading time: 7 minutes As we all look to 2021, what are the pharmaceutical industry trends to build into your life sciences marketing strategy? But today, the need to satisfy patients, providers, payers, regulatory agencies, and shareholders alike — while staying ahead of the competition — takes the right technologies at the right time. .
And the findings are clear: Without a positive, up-to-date, and lively online presence, healthcare practices are falling behind and losing patients to the competition. Since 2019, Press Ganey has gathered patient surveys to produce an annual report of what is driving them to pick one provider over another.
Can you tell us about your 2021 Highly Cited Researchers? In January 2021, he planned and guided the erection of the prefab COVID-19 Screening Station with Dr. Nan-Yao Lee, Director of the Infectious Disease Control Center, to help the screening go smoothly. Today, we speak with National Cheng Kung University (NCKU) in Taiwan.
Leverage intelligence for immediate insight into competitive data that helps sales teams create stronger targeting strategies and personalized, highly contextual customer experiences. Transform the HCP relationship to combat the decline in face-to-face relationships. Trend 3: Going beyond the pill.
Meet the guest: Terrence Wiggins is a dynamic leader with over two decades of experience in the MedTech industry and is currently the Global Marketing Director at Cook Medical, a role he has held since December 2021.
What are the traits of a great salesperson in 2021? Here’s something world class sales organization understand: Especially in B2B sales, establishing your competitive advantage is often less about your solutions and more about the day-to-day actions of your sales professionals. Best Practices of World Class Sales Organizations.
However, the 2021 approval of AstraZeneca’s Saphnelo in the US will mean increasing competition for Benlysta in the coming years. Furthermore, similar to GSK’s strategy with Benlysta, AstraZeneca initiated the Phase III TULIP subcutaneous (SC) trial in SLE using subcutaneous delivery of Saphnelo in June 2021.
This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA).
Increasing competition for talent, as well as the uncertainty of remote versus in-person workspaces, impacts new hire engagement. According to Gallup’s monthly employment trends, the percentage of employees working from home full-time (25%) and some of the time (20%) remained steady between July and September 2021. EcoVadis.com.
The appointment might raise some eyebrows given Roche’s need to drive pharma sales as it copes with the loss of patent protection on an earlier generation of antibody-based therapies – now being hit by biosimilar competition – but Schwan is confident Schinecker is the right man to lead the company forward.
Pharma pushes for UK medicine scheme revision Drug pricing was considered as the most negative emerging regulatory and macroeconomic trend, impeding growth for the industry, based on GlobalData’s 2019, 2020, 2021, and 2022 industry outlooks.
Competitiveness. India has built on its 2021 gains with a huge 15 percent improvement. This implies that the emerging pharma nations are improving fast, narrowing the disparity between the first and last rankers, suggesting increased competition in the global manufacturing market will be experienced in the upcoming year.
We apply Clarivate brand IP and analytics, first unveiled in our Top 100 Best Protected Global Brands 2021 , to better understand luxury’s ‘brandscape.’. The previously clear lines between sectors are blurring and the competitive set is widening. 4] VentureBeat, “Mythical launches Burberry NFTs in Blankos Block Party” , August 2021.
Highly Cited Researchers 2021 are based at more than 1,300 institutions. The Highly Cited Researchers campaign is an opportunity to introduce Korea University’s research competitiveness to our audience.”. They can generate new value and motivate new researchers by driving research-oriented competitiveness.
The deal is expected to close by the end of 2022, subject to approval by the relevant competition authorities. In 2021, Grünenthal acquired Mestex AG , a Swiss biotech, and its clinical phase medicine resiniferatoxin (MTX-071) for the intra-articular treatment of pain associated with osteoarthritis of the knee.
The latest market study report from the Competition Bureau has provided recommendations to health care providers (HCPs) on how to improve the ways they work within Canada’s public health system. The new report states that digital health care is not being used to its full potential in Canada.
The global life sciences mergers and acquisitions (M&A) investment totalled $105 billion in the first 11 months of 2022, with total deal value well down on 2021. Global M&A activity in 2022. EY’s research observed an overall drop in 2022 M&A investment worldwide.
In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.
A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation.
In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.
The new pivotal study in TRS will run in parallel to Newron’s ongoing phase 3 trial (Study 008A) of evenamide versus placebo over four weeks in patients with schizophrenia, which started in September 2021 and is due to generate results in the first half of this year.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content